Investigation of expression of 5T4 antigen in cervical cancer
- PMID: 2404512
- PMCID: PMC1971310
- DOI: 10.1038/bjc.1990.21
Investigation of expression of 5T4 antigen in cervical cancer
Abstract
A monoclonal antibody detecting amniotrophoblastic antigen 5T4 has shown reactivity against various neoplastic cell lines and tumour specimens but with a relatively restricted normal tissue expression. This antibody has been investigated as a potential indicator of premalignant changes identified as cervical intra-epithelial neoplasia and malignant cervical lesions using immunohistochemistry on frozen tissue biopsies. The basal cells of normal cervical stratified epithelium exhibited faint staining, but a general increase in intensity and extent of specific labeling of this tissue was seen from the first premalignant stage through to carcinoma. In most cases, this was in accordance with the distribution of dysplastic cells, and was accompanied by increased specific staining of the stromal tissue. All invasive squamous carcinomas of the cervix were 5T4 antigen positive. Common inflammatory non-malignant diseases did show a certain degree of epithelial and stromal reactivity. These results, showing 5T4 reactivity with neoplastic and pre-neoplastic lesions, may provide a quantitative basis for its potential use as a tumour marker in the immunochemical detection on immunoassay of cervical cancer.
Similar articles
-
Alterations in the expression of selected MHC antigens in premalignant lesions and squamous carcinomas of the uterine cervix.Acta Obstet Gynecol Scand. 2003 Dec;82(12):1146-52. doi: 10.1046/j.1600-0412.2003.00252.x. Acta Obstet Gynecol Scand. 2003. PMID: 14616262
-
Cervical carcinoma antigen: distribution in neoplastic lesions of the uterine cervix and comparison to other tumor markers.Gynecol Oncol. 1988 May;30(1):63-70. doi: 10.1016/0090-8258(88)90047-9. Gynecol Oncol. 1988. PMID: 2452772
-
Expression of the CA1 determinant by carcinomas and by non-malignant epithelial cells in oral lesions.Br J Cancer. 1983 Oct;48(4):527-31. doi: 10.1038/bjc.1983.225. Br J Cancer. 1983. PMID: 6354238 Free PMC article.
-
The antigenicity and immunology of human cervical squamous cell carcinoma: a review.Am J Obstet Gynecol. 1981 Jun 1;140(3):329-36. doi: 10.1016/0002-9378(81)90283-0. Am J Obstet Gynecol. 1981. PMID: 7018244 Review.
-
Distribution of epithelial antigens in the human uterine cervix: a review.Arch Gynecol Obstet. 1989;246(2):61-84. doi: 10.1007/BF00934123. Arch Gynecol Obstet. 1989. PMID: 2684044 Review.
Cited by
-
Identification of Pre- and Post-Treatment Markers, Clinical, and Laboratory Parameters Associated with Outcome in Renal Cancer Patients Treated with MVA-5T4.Front Oncol. 2013 Jul 15;3:185. doi: 10.3389/fonc.2013.00185. eCollection 2013. Front Oncol. 2013. PMID: 23875174 Free PMC article.
-
Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4.Immunology. 2006 May;118(1):50-7. doi: 10.1111/j.1365-2567.2006.02338.x. Immunology. 2006. PMID: 16630022 Free PMC article.
-
Naptumomab estafenatox: targeted immunotherapy with a novel immunotoxin.Curr Oncol Rep. 2014 Feb;16(2):370. doi: 10.1007/s11912-013-0370-0. Curr Oncol Rep. 2014. PMID: 24445502 Free PMC article. Review.
-
An update on TroVax for the treatment of progressive castration-resistant prostate cancer.Onco Targets Ther. 2011;4:33-41. doi: 10.2147/OTT.S14271. Epub 2011 May 24. Onco Targets Ther. 2011. PMID: 21691576 Free PMC article.
-
Trophoblast glycoprotein recognised by monoclonal antibody 5T4 maps to human chromosome 6q14-q15.Hum Genet. 1990 Apr;84(5):455-8. doi: 10.1007/BF00195819. Hum Genet. 1990. PMID: 2323778
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical